Showing results (321-330 of 328) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 328 results.
Alzheimer'S Research & Therapy|September 22, 2023
Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairmentNidhi S Mundada, Julio C Rojas, Lawren Vandevrede, et al.
Alzheimer'S Research & Therapy|May 15, 2020
Relevance of biomarkers across different neurodegenerative diseasesAlexander J Ehrenberg, Ayesha Khatun, Emma Coomans, et al.
Alzheimer'S Research & Therapy|June 11, 2020
Correction to: Relevance of biomarkers across different neurodegenerative diseasesAlexander J Ehrenberg, Ayesha Khatun, Emma Coomans, et al.
Heart (British Cardiac Society)|December 1, 2023
Prehospital risk assessment and direct transfer to a percutaneous coronary intervention centre in suspected acute coronary syndromeJesse Demandt, Arjan Koks, Dennis Sagel, et al.
JAMA Neurology|April 3, 2023
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal SyndromeLawren VandeVrede, Renaud La Joie, Elisabeth H Thijssen, et al.
Nature Medicine|March 4, 2020
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degenerationElisabeth H Thijssen, Renaud La Joie, Amy Wolf, et al.
Nature Medicine|April 15, 2026
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degenerationMadison I J Honey, Yanaika S Hok-A-Hin, Elisabeth H Thijssen, et al.
The Lancet. Neurology|August 21, 2021
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance studyElisabeth H Thijssen, Renaud La Joie, Amelia Strom, et al.
Pageof 33